Drug Shortage Report for AXID

Last updated on 2022-01-07 History
Report ID 150740
Drug Identification Number 00778338
Brand name AXID
Common or Proper name Axid (Nizatidine)
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) NIZATIDINE
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100 CAPS
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-12-06
Estimated end date 2021-12-22
Actual end date 2021-12-22
Shortage status Resolved
Updated date 2022-01-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-01-07 French Compare
v3 2022-01-07 English Compare
v2 2021-12-08 French Compare
v1 2021-12-08 English Compare

Showing 1 to 4 of 4